Search

everythinglearnresearchcommunity

for

Search:↓

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Australia improved medical education and Canada focused on professionalism and patient safety.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

CuATSM speeds up wound healing and reduces scarring.

Fractional radiofrequency microneedling is as effective and safe as intralesional steroids for treating patchy alopecia areata, with fewer side effects.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Several doctors received research grants, new workshops and conferences were announced, and new officers were elected.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

FGF18 may influence hair loss in dogs.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Murine cytomegalovirus does not cause alopecia areata in these mice.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

The document provides a quiz for physicians to earn continuing medical education credits in facial plastic surgery.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.